About INVESCO GREAT WALL FUND MGMT CO LTD HKCONNECT INNOVATIVE DRUG ETF CNY

513780 invests in stocks. The fund's major sectors are Health Technology, with 94.95% stocks, and Commercial Services, with 1.39% of the basket. The assets are mostly located in the Asia region.

513780 top holdings are Innovent Biologics, Inc. and Wuxi Biologics (Cayman) Inc., occupying 9.84% and 9.73% of the portfolio correspondingly.

513780 assets under management is ‪1.13 B‬ CNY. It's risen 104.44% over the last month.

513780 fund flows account for ‪693.82 M‬ CNY (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.

513780 shares are issued by Invesco Great Wall Fund Management Co. Ltd. under the brand Invesco. The ETF was launched on Oct 16, 2024, and its management style is Passive.

513780 follows the CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.

513780 invests in stocks.

513780 price has risen by 35.08% over the last month, and its yearly performance shows a 51.65% increase. See more dynamics on 513780 price chart.
NAV returns, another gauge of an ETF dynamics, have risen by 37.37% over the last month, showed a 39.43% increase in three-month performance and has increased by 65.72% in a year.